ScottWLeeMD
Endocrinology • Loma Linda, CADiabetes, Lipid Metabolism
Clinical Professor of Medicine, Loma Linda University
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11370 Anderson St
Loma Linda, CA 92354Phone+1 909-558-2870
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1993 - 1996
Northwestern University The Feinberg School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1996 - 2026
WI State Medical License 1994 - 1997- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes Start of enrollment: 2005 Jun 01
- Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration Start of enrollment: 2002 Jun 01
- Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 383 citationsGlucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.Satish K. Garg, Stuart A. Weinzimer, William V. Tamborlane, Bruce A. Buckingham, Bruce W. Bode
Diabetes Technology & Therapeutics. 2017-03-01 - 415 citationsThreshold-based insulin-pump interruption for reduction of hypoglycemiaRichard M. Bergenstal, David C. Klonoff, Satish K. Garg, Bruce W. Bode, Melissa Meredith
The New England Journal of Medicine. 2013-07-17 - 132 citationsSafety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.Gregory P. Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, Dorothy I. Shulman, Timothy S. Bailey
Diabetes Technology & Therapeutics. 2019-01-08
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
